Cardiovascular risk factors in idiopathic compared to riskassociated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH-09-02-0104
Issue:2009: 102/4 (Oct) pp. 611-798
Pages:668-675

Cardiovascular risk factors in idiopathic compared to riskassociated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)

Beate Luxembourg1; Joern Schmitt2; Marek Humpich3; Matthias Glowatzki4; Dejan Dressler1; Erhard Seifried5;
Edelgard Lindhoff-Last1

1Department of Internal Medicine, Division of Vascular Medicine and Haemostaseology, University Hospital Frankfurt, Germany; 2Department
of Internal Medicine, Division of Cardiology, University Hospital Frankfurt, Germany; 3Department of Anesthesiology, Intensive Care Medicine
and Pain Management, University Hospital Frankfurt, Germany; 4SPSS GmbH München, Germany; 5Institute of Transfusion Medicine and
Immunohematology, Blood Transfusion Center of the German Red Cross, Frankfurt, Germany

Summary

There have recently been reports of an increased incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism (VTE) compared to patients with risk-associated VTE. The aim of our study was to evaluate whether elevated clotting factors, which have been linked to chronic subclinical inflammation and arterial thromboembolic disease, have a higher prevalence in idiopathic VTE compared to secondary VTE. Plasma fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP) levels were determined in a cohort of sex- and age-matched patients with unprovoked VTE (n=101), patients with secondary VTE (n=101), and controls (n=202). Fibrinogen and hs-CRP levels were higher in patients with idiopathic VTE (fibrinogen: median/range: 331/214–524 mg/dl; hs-CRP: median/interquartile range: 1.8/0.8–3.7 mg/l) than in those with risk-associated VTE (299/162–458 mg/dl, p=0.004; 1.5/0.8–2.2 mg/l, p=0.05) and controls (302/185–644 mg/dl, p=0.001; 1.2/0.5–2.2  mg/l, p=0.02). Fibrinogen levels in the upper tertile of the controls were seen in 53% of patients with unprovoked VTE, compared to 35% of patients with secondary VTE. According to their hs-CRP levels (>3 mg/l), 26% of patients with idiopathic VTE were categorised as being at high risk for cardiovascular disease, as opposed to just 9% of those with risk-associated VTE. Factor VIII activity was significantly higher in patients with both idiopathic and secondary VTE than in controls, with the highest median value in patients with idiopathic VTE. Our data show that markers of inflammation, such as hs-CRP, fibrinogen, and factor VIII, are at higher levels in patients with idiopathic compared to secondary VTE, supporting the hypothesis that idiopathic VTE and arterial thromboembolism share common risk factors.

Keywords

Venous thrombosis, factor VIII, fibrinogen, C-reactive protein

DOI

http://dx.doi.org/10.1160/TH-09-02-0104

You may also be interested in...

1.

Moniek P. M. de Maat1,2, Jonna Skov Madsen3, Bente Langdahl4, Else Marie Bladbjerg1, Charlotte Landbo Tofteng5, Bo Abrahamsen4, Lars Rejnmark6, Kim Brixen4, Kaare Christensen7, Jørgen Jespersen1, Søren Risom Kristensen8

Thrombosis and Haemostasis 2007 97 2: 234-239

http://dx.doi.org/10.1160/TH06-08-0426

2.

John T. Horan, Charles W. Francis, Ann R. Falsey, John Kolassa, Brian H. Smith, William J. Hall

Thrombosis and Haemostasis 2001 85 2: 245-249

3.

Felipe Guerrero1 , Catherine Arnaud2 , Francoise Nguyen1 , Bernard Boneu 1 , Pierre Sié1

Thrombosis and Haemostasis 2006 95 4: 728-734

http://dx.doi.org/10.1160/TH05-08-0593



Articles

You've 545 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...